| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |